Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,958 | 254 | 99.7% |
| Education | $7.69 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $537.95 | 63 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $434.47 | 32 | $0 (2019) |
| Amgen Inc. | $219.82 | 13 | $0 (2019) |
| Novo Nordisk Inc | $205.69 | 25 | $0 (2019) |
| PFIZER INC. | $197.46 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $186.77 | 13 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $166.45 | 11 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $145.81 | 12 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $123.40 | 7 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $112.84 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.59 | 2 | PFIZER INC. ($24.41) |
| 2019 | $724.51 | 71 | PFIZER INC. ($117.23) |
| 2018 | $1,000 | 91 | GlaxoSmithKline, LLC. ($266.56) |
| 2017 | $1,194 | 92 | GlaxoSmithKline, LLC. ($219.19) |
All Payment Transactions
256 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: PAIN | ||||||
| 05/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/14/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neuroscience | ||||||
| 09/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Diabetes | ||||||
| 09/20/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Diabetes | ||||||
| 09/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: Diabetes | ||||||
| 09/10/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.31 | General |
| Category: Diabetes | ||||||
| 09/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/05/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ORTHOPEDICS | ||||||
| 08/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: DIABETES | ||||||
| 08/09/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Diabetes | ||||||
| 07/23/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.17 | General |
| Category: Diabetes | ||||||
| 07/12/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/11/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Bone Health | ||||||
| 06/28/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/20/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 457 | 663 | $126,938 | $45,443 |
| 2022 | 17 | 536 | 935 | $156,120 | $55,979 |
| 2021 | 19 | 580 | 1,205 | $170,486 | $62,566 |
| 2020 | 14 | 464 | 825 | $124,522 | $44,621 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 210 | $48,817 | $18,391 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 197 | $30,229 | $10,724 | 35.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 29 | 29 | $4,263 | $3,724 | 87.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 40 | 40 | $4,975 | $2,877 | 57.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 30 | $12,840 | $2,799 | 21.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,587 | $1,843 | 40.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 30 | $8,940 | $1,737 | 19.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,989 | $1,196 | 60.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $3,564 | $724.15 | 20.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 13 | $2,171 | $648.60 | 29.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $759.00 | $429.38 | 56.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 36 | $3,804 | $349.68 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 263 | $53,358 | $22,968 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 122 | 251 | $35,250 | $14,706 | 41.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 73 | $21,097 | $3,988 | 18.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 27 | $14,472 | $2,582 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 17 | $4,726 | $2,367 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $2,272 | $2,094 | 92.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 25 | 25 | $2,894 | $1,647 | 56.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 19 | 29 | $7,859 | $1,574 | 20.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 20 | 27 | $2,484 | $1,350 | 54.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 20 | $5,760 | $1,016 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,274 | $769.60 | 60.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 33 | $1,617 | $345.18 | 21.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 11 | 11 | $803.00 | $212.36 | 26.4% |
About Dr. Govind Singh, M.D
Dr. Govind Singh, M.D is a Family Medicine healthcare provider based in Colfax, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730199464.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Govind Singh, M.D has received a total of $2,966 in payments from pharmaceutical and medical device companies, with $46.59 received in 2024. These payments were reported across 256 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,958).
As a Medicare-enrolled provider, Singh has provided services to 2,037 Medicare beneficiaries, totaling 3,628 services with total Medicare billing of $208,609. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Geriatric Medicine
- Location Colfax, WA
- Active Since 08/08/2006
- Last Updated 10/14/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730199464
Products in Payments
- XARELTO (Drug) $291.97
- Ozempic (Drug) $146.47
- ANORO (Drug) $144.91
- INVOKANA (Drug) $142.50
- ADVAIR (Drug) $132.65
- Prolia (Biological) $118.77
- BREO (Drug) $109.24
- LYRICA (Drug) $105.31
- EUFLEXXA (Device) $99.40
- ENTRESTO (Drug) $99.14
- FARXIGA (Drug) $95.23
- JARDIANCE (Drug) $85.02
- Amitiza (Drug) $77.70
- TRELEGY ELLIPTA (Drug) $72.94
- SOLIQUA (Drug) $71.99
- CHANTIX (Drug) $67.74
- TOUJEO (Drug) $62.99
- SYMBICORT (Drug) $60.38
- ELIQUIS (Drug) $55.47
- VRAYLAR (Drug) $53.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Colfax
Mark Parsons, Md, MD
Family Medicine — Payments: $3,931
Dr. William Mellor, M.d, M.D
Family Medicine — Payments: $3,737
Gary Candelaria, D.o, D.O
Family Medicine — Payments: $757.70
Anthony Lundberg, Do, DO
Family Medicine — Payments: $486.84
Sarah Fielding, Md, MD
Family Medicine — Payments: $125.78
Dr. Brent Conrad, Md, MD
Family Medicine — Payments: $42.37